Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"Only thing I can think of is that IPIX did heavy exclusion of subjects with SOM in cisplatin Q3W group and FDA thinks they do belong."

I may be showing my ignorance here but an inclusion criteria is a characteristic that ALL tested patients must have, isn't it?

"4. Have a plan to receive a standard cisplatin chemotherapy regimen administered weekly (30-40 mg/m2) or approximately every 21 days (80-100 mg/m2)"
https://clinicaltrials.gov/ct2/show/NCT02324335?term=brilacidin&rank=1

I can't tell if that's relevant to your discussion or not but it seems to be.